Divided Fed. Circ. Nixes Rehearing Of Mirapex Spat
The U.S. Court of Appeals for the Federal Circuit will not give a panel rehearing or en banc rehearing to Mylan Pharmaceuticals Inc. in its case against Boehringer, the court said in a decision handed down Friday.
The decision cements the validity...
To view the full article, register now.